Key result
ASGR2 and NPL show high diagnostic efficacy as candidate biomarkers for AMI.
Why the study?
Current diagnostic and prognostic biomarkers for AMI remain limited, and protein succinylation may offer novel biomarker candidates.
Cross-Sectional (n=372)
No
ASGR2 and NPL are identified as novel succinylation-annotated candidate biomarkers for acute myocardial infarction, potentially linked to monocyte-related inflammatory remodeling.
Supports ASGR2/NPL validation as AMI biomarkers; leaves open clinical utility pending prospective trials.
Background Current diagnostic and prognostic biomarkers for acute myocardial infarction (AMI) remain limited. Protein succinylation may provide novel biomarker candidates for AMI. Methods Weighted gene co-expression network analysis (WGCNA) was applied to GSE66360 to identify AMI-related modules, and succinylation-annotated genes were retrieved from GeneCards. Using GSE66360 as the training set and GSE48060, GSE60993, and GSE59867 as validation sets, we evaluated 107 predefined machine-learning pipelines and assessed hub genes by differential expression and ROC analysis. Immune infiltration and gene-cell correlations were assessed with CIBERSORT. Single-cell transcriptomics examined hub-gene expression across monocyte subsets in plaque rupture (PR) and non-plaque rupture (NPR) cases, and exploratory pseudotime analysis assessed monocyte-state heterogeneity. ELISA was used to measure circulating protein levels. Results Integrating WGCNA with GeneCards yielded 18 succinylation-annotated AMI genes. Among the evaluated pipelines, Stepglm[both] + plsRglm and Stepglm[backward] + plsRglm showed relatively favorable external validation performance. ROC and differential expression analyses prioritized ASGR2 and NPL as exploratory candidate biomarkers. Both genes correlated positively with monocytes, particularly classical monocytes. Classical monocytes were more abundant in NPR than PR samples. ASGR2 and NPL showed exploratory expression trends along an inferred pseudotime axis. ELISA showed elevated plasma levels of ASGR2 and NPL in AMI patients compared with control individuals. Conclusion ASGR2 and NPL were identified as hypothesis-generating candidate biomarkers associated with acute myocardial infarction. Given the limited training sample size and the high number of evaluated machine-learning pipelines, these findings remain exploratory and require independent prospective validation before clinical translation. Their enrichment in monocytes, particularly classical monocytes, suggests a potential association with monocyte-related inflammatory remodeling.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) conducted a cross-sectional in Acute myocardial infarction (n=372). ASGR2 and NPL expression vs. Healthy controls was evaluated on Diagnostic performance (AUC) for acute myocardial infarction (AUC 0.844 for ASGR2 and 0.756 for NPL). ASGR2 and NPL were identified as candidate diagnostic biomarkers for acute myocardial infarction, demonstrating high diagnostic efficacy with validation AUCs of 0.844 and 0.756, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: